Tag:

Exclusive

Health

New ‘keto pill’ mimics popular diet without giving up carbs

by Chief Editor
written by Chief Editor

The Future of Weight Loss: Could a Pill Replace the Keto Diet?

For years, the ketogenic diet – a high-fat, low-carb regimen – has been a popular, albeit restrictive, path to weight loss. But what if you could reap the metabolic benefits of keto without sacrificing your favorite foods? Bloom Science believes they’ve found a way, and it comes in capsule form.

How BL-001 Aims to Mimic Keto Without the Restrictions

Bloom Science is developing BL-001, an experimental drug designed to replicate the metabolic effects of the ketogenic diet. The core idea, as explained by CEO Christopher Reyes, is to “translate some of the metabolic biology of the ketogenic diet into a therapy people may be able to take as an oral daily capsule.” Unlike the keto diet, which requires strict adherence to a specific macronutrient ratio, BL-001 aims to deliver results without dietary limitations.

The pill isn’t about restricting calories; it’s about manipulating metabolism. BL-001 is composed of live bacteria naturally found in the gut microbiome. Researchers hypothesize that specific bacterial strains can influence fat metabolism and ketogenesis – the process of the body burning fat for fuel.

Phase 1 Trial Results: Promising Early Signs

Early results from a Phase 1 clinical trial are encouraging. Overweight participants receiving the highest dose of BL-001 experienced a placebo-adjusted weight loss of 2.3% over 28 days, with some individuals losing up to 4.9%. Importantly, 80% of those who lost weight maintained their results two weeks after stopping the treatment. The trial also reported no serious adverse events.

Currently, Bloom Science is conducting Phase 1b trials, enrolling obese adults to assess the drug’s effects over a 12-week period.

Beyond Weight Loss: Potential Applications for Neurological Disorders

Whereas initially focused on obesity, Bloom Science’s research extends beyond weight management. The company is also exploring BL-001’s potential to treat Dravet syndrome, a rare and severe form of epilepsy. This highlights the broader therapeutic possibilities of targeting the gut-brain axis – the complex communication network between the gut microbiome and the brain.

BL-001 vs. GLP-1 Drugs: A New Contender?

The emergence of GLP-1 drugs like Ozempic and Zepbound has revolutionized weight loss treatment. Though, these medications require injections, and some patients experience gastrointestinal side effects. Bloom Science aims to offer an alternative for individuals who qualify for GLP-1s but prefer an oral medication with potentially fewer side effects.

It’s still too early to definitively compare BL-001 to GLP-1 drugs, but the potential for a convenient, oral therapy is significant.

Frequently Asked Questions

What is the gut microbiome?
It’s the collection of viruses, bacteria, fungi, and other microorganisms that live in your digestive tract and play a crucial role in your health.
What is ketogenesis?
It’s the metabolic process where the body burns fat for fuel instead of carbohydrates.
Is BL-001 currently available?
No, BL-001 is still in clinical development and is not yet available to the public.
What are live biotherapeutics?
These are therapies that use live microorganisms to treat or prevent disease.

Want to stay updated on the latest breakthroughs in microbiome research? Visit Bloom Science’s website to learn more and follow their progress.

0 comments
0 FacebookTwitterPinterestEmail
Entertainment

Exclusive: Daniel Craig Offered Villain Role In The Batman Part II

by Chief Editor
written by Chief Editor

Daniel Craig Eyes Role in The Batman Part II: A Deep Dive into Christopher Dent and the Future of DC Villains

Warner Bros.’ The Batman, released in March 2022, proved a massive success, grossing over $770 million worldwide. The sequel, The Batman Part II, is now in pre-production, and casting news is beginning to surface. Exclusive information obtained by GIANT FREAKIN ROBOT reveals that Daniel Craig has been offered the role of Christopher Dent, a pivotal character in the Batman mythos.

Who is Christopher Dent and Why Does He Matter?

Christopher Dent isn’t a villain audiences will immediately recognize. He’s the abusive, alcoholic father of Harvey Dent, who ultimately becomes the tragic villain Two-Face. Modern comic book interpretations portray Christopher as a deeply troubled figure, inflicting both physical and psychological abuse on his family. He’s known for forcing young Harvey to flip a coin to determine his fate, a chilling precursor to Two-Face’s duality.

The inclusion of Christopher Dent as one of the three main villains in The Batman Part II signals a deeper exploration of Harvey Dent’s origins and the factors that contribute to his descent into villainy. This approach aligns with the trend of complex villain portrayals seen in recent superhero films.

The Ripple Effect of Complex Villains in Superhero Cinema

For years, superhero films often featured one-dimensional villains. However, films like Joker (2019) demonstrated the audience appetite for nuanced, psychologically driven antagonists. This shift has prompted studios to delve deeper into the backstories and motivations of their villains, creating more compelling narratives.

The casting of Daniel Craig, known for his intense and layered performances, suggests Warner Bros. Intends to treat Christopher Dent with similar depth. Should Craig decline, Liam Neeson is reportedly the next choice, indicating a continued focus on securing a high-caliber actor for the role.

Scarlett Johansson’s Involvement and the Expanding DC Universe

This casting news follows confirmation that Scarlett Johansson will also appear in The Batman Part II. This suggests a potential broadening of the DC cinematic universe, potentially incorporating characters from different corners of the DC Comics canon. The source confirming these details has a proven track record, previously breaking the news of Johansson’s casting.

The Future of the Batman Franchise: A Darker Tone?

Matt Reeves’ The Batman distinguished itself with its gritty, noir-inspired aesthetic and focus on detective work. The introduction of characters like Christopher Dent, and the exploration of their complex motivations, suggests that The Batman Part II will continue this darker, more psychologically driven approach. This contrasts with some other superhero franchises that lean towards more fantastical or comedic elements.

FAQ

  • Who is Christopher Dent? He is the abusive father of Harvey Dent/Two-Face, depicted as a violent and psychologically damaging figure.
  • Who is currently slated to play Christopher Dent? Daniel Craig has been offered the role, with Liam Neeson as a backup choice.
  • Will Scarlett Johansson be in The Batman Part II? Yes, it has been confirmed that Scarlett Johansson will appear in the film.
  • What kind of villain will Christopher Dent be? He will be one of the three main villains in the film.

Pro Tip: Keep an eye on casting announcements for The Batman Part II. The choices made will likely indicate the overall tone and direction of the film.

Want to stay up-to-date on all the latest superhero movie news? Explore more articles on GIANT FREAKIN ROBOT and join the conversation!

d, without any additional comments or text.
[/gpt3]

0 comments
0 FacebookTwitterPinterestEmail
Tech

AI Bill Sponsor Targeted by Big Tech in NY Congressional Race

by Chief Editor
written by Chief Editor

Tech Billionaires Wage War in New York: The Battle for AI Regulation

New York’s 12th congressional district has become ground zero in a high-stakes battle over the future of artificial intelligence. Assembly Member Alex Bores, a Democrat running for Congress, is facing a relentless barrage of attack ads funded by a super PAC backed by some of Silicon Valley’s biggest names. The core issue? Bores’ push for AI regulation.

From Palantir to Political Target

Bores’ story is complex. He spent nearly five years at Palantir, the controversial data analytics firm known for its work with government agencies, including U.S. Immigration and Customs Enforcement (ICE). He quit Palantir in 2019, citing moral objections to the company’s ICE contracts. Now, that past is being weaponized against him.

Ads accuse Bores of profiting from technology used in deportations, a claim he disputes, stating he never worked directly on the ICE contract. However, his former employer, Palantir, is now indirectly funding his opposition through the super PAC, Leading the Future.

The $125 Million Offensive

Leading the Future has raised a staggering $125 million to support candidates who oppose strict AI regulation and to undermine those, like Bores, who advocate for it. The PAC’s backers include Palantir co-founder Joe Lonsdale, OpenAI President Greg Brockman, and venture capital firm Andreessen Horowitz. They’ve already committed at least $10 million to oppose Bores’ campaign.

“They’re targeting me to make an example of me,” Bores told TechCrunch. He believes his tech background – including his computer science degree and experience at Palantir – makes him a particularly potent threat to their agenda.

The RAISE Act and the Fight for State Control

Bores’ political troubles stem, in part, from sponsoring the RAISE Act in New York. This law requires large AI labs to have publicly available safety plans and report catastrophic safety incidents. Although considered a relatively mild regulation, it sparked outrage among industry leaders who fear a patchwork of state laws could stifle innovation.

The tech industry, backed by former President Trump’s executive order, is pushing for federal-level AI regulation, believing it will preempt stricter state laws. Bores, however, argues that states should retain the right to regulate AI in the absence of a comprehensive federal framework.

A Broader Trend: Big Tech’s Political Spending

The battle over Bores’ campaign is not an isolated incident. Meta has invested $65 million in super PACs to elect state-level candidates friendly to the tech industry. AI companies and executives collectively donated at least $83 million in 2025 to federal campaigns, and committees. This influx of money underscores the growing political influence of the tech sector.

Interestingly, Bores has also received support from a PAC backed by Anthropic, called Public First Action, which is spending $450,000 to counter the attacks. This highlights a division within the AI industry itself, with some companies advocating for greater transparency and oversight.

What Does This Mean for the Future of AI Regulation?

The New York congressional race is a microcosm of a larger struggle: how to balance innovation with responsible AI development. The massive spending by tech companies signals their determination to shape the regulatory landscape in their favor. The outcome of this election, and similar contests across the country, could have profound implications for the future of AI.

FAQ

Q: What is the RAISE Act?
A: It’s a New York law requiring large AI labs to have publicly available safety plans and report safety incidents.

Q: Who is funding the attacks against Alex Bores?
A: A super PAC called Leading the Future, backed by Palantir co-founder Joe Lonsdale, OpenAI President Greg Brockman, and other Silicon Valley investors.

Q: Why is the AI industry so opposed to state-level regulation?
A: They fear a patchwork of state laws will create uncertainty and hinder innovation.

Q: What is Palantir’s role in this conflict?
A: A Palantir co-founder is funding the super PAC attacking Bores, despite Bores having previously worked at and left the company due to concerns about its ICE contracts.

Did you know? The amount of money being spent on this congressional race far exceeds the typical spending for a New York State Assembly race.

Pro Tip: Stay informed about AI regulation efforts in your state and contact your representatives to voice your concerns.

Want to learn more about the evolving landscape of AI and its impact on society? Explore our other articles on technology and politics.

0 comments
0 FacebookTwitterPinterestEmail
Entertainment

‘Love Island USA’ Star Nic Vansteenberghe Gives Relationship Update

by Chief Editor
written by Chief Editor

Love Island USA’s Nic and Olandria: A Modern Romance in the Age of Reality TV

Love Island USA stars Nic Vansteenberghe and Olandria Carthen continue to captivate fans with their blossoming relationship, proving that connections forged on reality television can thrive beyond the villa. Their journey, marked by initial hesitation and fan-fueled encouragement, offers a glimpse into the evolving dynamics of modern romance and the impact of social media on relationship building.

The Slow Burn: From Villa Chemistry to Real-World Romance

Nic and Olandria’s story wasn’t instant. Their connection began with a kiss on day one of Season 7, followed by a blindfolded kiss during a challenge where Olandria didn’t even know it was Nic. Despite initial pairings with other islanders, a clear chemistry persisted, recognized immediately by viewers who coined the ship name “Nicolandria.” It wasn’t until Episode 30, after both were dumped from Casa Amor, that they finally explored their feelings, finishing the season in second place. This slow burn, fueled by external support, highlights a growing trend: audiences actively shaping the narratives of reality TV romances.

Navigating Fame and Maintaining Authenticity

Transitioning from the controlled environment of the villa to the scrutiny of public life presents unique challenges. Nic acknowledges the difficulty of navigating rumors and maintaining privacy. He emphasizes the importance of relying on trusted sources – family and friends – to discern fact from fiction. This struggle reflects a broader issue for reality TV stars: balancing newfound fame with the desire for authentic relationships.

The Power of Shared Experiences: Building Bonds Beyond the Show

The friendships forged on Love Island USA have proven resilient. Nic recently spent time with fellow islanders TJ Palma, Iris Kendall, Hannah Fields, and Rob Rausch, demonstrating the lasting impact of shared experiences. These connections provide a support system and a sense of normalcy amidst the whirlwind of post-show life.

Self-Care and the Modern Man: A Recent Focus

Nic’s partnership with Dove Men+Care underscores a growing emphasis on self-care for men. He admits to previously lacking a consistent hygiene routine, a revelation that highlights a shift in societal expectations. The Dove Men+Care Mood-Boosting Aluminum-Free Deodorant Collection, with its focus on fragrance and mindset, aligns with this trend, offering products designed to enhance confidence and wellbeing.

Source: Dove Men+Care

Nic Vansteenberghe revealed his favorite scent is ‘Olandria-approved.’

Frequently Asked Questions

  • Are Nic and Olandria still together? Yes, as of February 24, 2026, Nic and Olandria are still dating and their relationship is thriving.
  • How did Nic and Olandria first connect on Love Island USA? They shared a kiss on day one and continued to have a connection throughout the season, despite initially pursuing other relationships.
  • What role did fans play in their relationship? Fans actively supported their connection, coining the ship name “Nicolandria” and encouraging them to explore their feelings.

The story of Nic and Olandria offers a compelling case study of modern romance, shaped by the unique pressures and opportunities of reality television and social media. Their continued success suggests a future where audience engagement and authentic connection can lead to lasting relationships.

d, without any additional comments or text.
[/gpt3]

0 comments
0 FacebookTwitterPinterestEmail
Sport

Breanna Stewart: Why WNBA Star is Playing in Turkey

by Chief Editor
written by Chief Editor

Breanna Stewart’s Fenerbahçe Deal: A Sign of Shifting Power in Women’s Basketball?

Modern York Liberty star Breanna Stewart’s unexpected return to Fenerbahçe Opet in Turkey is sending ripples through the WNBA. The two-time WNBA MVP accepted an offer she described as “something that I couldn’t refuse,” raising questions about the financial realities facing top WNBA players and the future of player movement.

The Allure of Overseas Opportunities

Stewart’s decision, coming after she co-founded Unrivaled – an initiative designed to retain WNBA stars playing in the US during the offseason – highlights a persistent challenge in women’s basketball: the significant disparity in pay between the WNBA and overseas leagues. Although Unrivaled aims to provide more opportunities stateside, the financial incentives offered by teams like Fenerbahçe remain substantial.

The offer from Fenerbahçe was tailored to Stewart’s needs, with the club demonstrating a willingness to compromise on scheduling and other stipulations to secure her participation in the EuroLeague Final Six. This level of flexibility and financial commitment is not always mirrored in the WNBA, where the salary cap and other constraints can limit player earnings.

CBA Negotiations and the Future of the WNBA

This move arrives at a critical juncture for the WNBA, as the league prepares for Collective Bargaining Agreement (CBA) negotiations. As noted by High Post Hoops, Stewart’s decision could potentially complicate these negotiations, underscoring the need for the WNBA to address player compensation and create a more sustainable financial model that can retain top talent.

The current WNBA CBA, ratified in 2020, represented a significant step forward in terms of player pay and benefits. Yet, the gap between WNBA salaries and those offered overseas remains a major concern. Players like Stewart, with significant marketability and on-court performance, are particularly attractive to international teams.

EuroLeague’s Growing Influence

Fenerbahçe’s aggressive pursuit of Stewart is indicative of the EuroLeague’s increasing investment in women’s basketball. The league is attracting top players from around the world, enhancing its competitiveness and visibility. Stewart’s return to Fenerbahçe, a team she previously played for, demonstrates the appeal of established programs with a track record of success.

Swish Appeal points out that Stewart’s participation in the EuroLeague Final Six is the extent of her commitment, suggesting a focused approach that minimizes disruption to her WNBA season. This arrangement allows her to capitalize on a lucrative opportunity while still prioritizing her WNBA career.

What This Means for Player Empowerment

Stewart’s ability to negotiate a deal that accommodates her needs and maximizes her earning potential represents a growing trend of player empowerment. Athletes are increasingly taking control of their careers and seeking opportunities that align with their financial and professional goals.

The rise of player-led initiatives like Unrivaled further demonstrates this trend. By creating alternative platforms for competition and income generation, players are challenging the traditional power structures within the sport.

FAQ

Q: Why did Breanna Stewart decide to play in Turkey?
A: She received an offer from Fenerbahçe that she described as “something that I couldn’t refuse,” indicating a significant financial incentive.

Q: Will this affect her WNBA season?
A: Stewart will only play in the EuroLeague Final Six, minimizing disruption to her WNBA schedule.

Q: What does this mean for the WNBA’s CBA negotiations?
A: It highlights the need for the WNBA to address player compensation and create a more competitive financial landscape.

Q: Is Unrivaled still a priority for Breanna Stewart?
A: Yes, she co-founded Unrivaled to provide more opportunities for WNBA players in the US, but also recognized the value of this specific overseas offer.

Did you realize? Breanna Stewart is a two-time WNBA MVP and Olympic gold medalist.

Pro Tip: Keep an eye on CBA negotiations – they will significantly impact the future of the WNBA and its players.

Want to learn more about the WNBA and its players? Visit the official WNBA website.

Share your thoughts on Breanna Stewart’s decision in the comments below! Don’t forget to subscribe to our newsletter for the latest updates on women’s basketball.

0 comments
0 FacebookTwitterPinterestEmail
Tech

Former Founders Fund VC Sam Blond launches AI sales startup to upend Salesforce 

by Chief Editor
written by Chief Editor

The Rise of AI-Powered Sales: Will Monaco Unseat Salesforce?

The sales technology landscape is undergoing a seismic shift, and a new contender, Monaco, has officially entered the arena. Founded by former Founders Fund VC Sam Blond and his brother Brian, Monaco isn’t just another AI sales platform; it’s a hybrid approach blending cutting-edge artificial intelligence with the expertise of seasoned human salespeople. This strategy is attracting significant investment – $35 million to date – and the attention of industry giants.

A Different Approach to AI in Sales

Many AI sales startups are focused on complete automation, aiming to replace human sales representatives altogether. Monaco takes a different tack. While leveraging AI to automate tasks like prospecting, email outreach, and meeting scheduling, it retains a “human-in-the-loop” approach. Experienced salespeople monitor the AI, ensuring accuracy and providing a crucial layer of quality control. This is a key differentiator, as Monaco doesn’t deploy AI agents pretending to be sales reps.

This model addresses a critical concern in the rapidly evolving AI space: the potential for “hallucinations” or inaccurate information generated by AI. By having humans oversee the process, Monaco aims to deliver reliable results and build trust with potential customers.

Funding and Backing Signal Confidence

Monaco’s $35 million in funding, led by Founders Fund with participation from Human Capital, speaks volumes about investor confidence. The company has also secured backing from prominent angels, including Stripe founders Patrick and John Collison, Y Combinator chief Garry Tan, and Greenoaks Capital founder Neil Mehta. This level of support suggests that investors believe Monaco’s hybrid approach has the potential to disrupt the existing sales tech market.

Targeting the Underserved Seed and Series A Market

Monaco is specifically targeting young seed and Series A-level startups. These companies often lack the resources to build a robust sales team and implement a complex sales technology stack. Monaco offers an all-in-one solution, providing an AI-native CRM and a prospect database comparable to ZoomInfo, all at a flat-fee price point designed to be more affordable than established players like Salesforce and HubSpot.

The Crowded Field and the Search for the “Cursor for Sales”

The AI sales tech market is undeniably crowded. Numerous startups, including Attio, Clay, Conversion, 11x, Artisan, and 1mind, are vying for market share. Even established players like Salesforce and HubSpot are integrating AI into their existing platforms. Sam Blond acknowledges this competition, stating there isn’t yet a clear leader – a “Cursor for sales,” referencing the popular AI coding tool – but believes one will emerge.

Blond believes Monaco is positioned to be that leader, leveraging his extensive sales experience and a focus on providing a comprehensive solution that combines technology and human expertise.

A Culture Built for Sales Success

Monaco’s internal culture reflects its commitment to sales. The company employs approximately 40 people, primarily experienced salespeople, and its office environment is designed to foster motivation and celebrate success. An office gong rings out every time the AI secures a meeting with a prospect, creating a tangible sense of achievement.

What Does This Mean for the Future of Sales?

Monaco’s emergence signals a potential shift in the sales technology landscape. The company’s success could pave the way for more hybrid AI-human sales models, where AI handles repetitive tasks and provides data-driven insights, while human salespeople focus on building relationships and closing deals.

This approach could be particularly beneficial for startups and small businesses that demand to maximize their sales efficiency without sacrificing the personal touch. It also highlights the importance of ongoing training and oversight in the age of AI, ensuring that AI tools are used effectively and ethically.

FAQ

What is Monaco?

Monaco is an AI-powered sales platform that combines artificial intelligence with experienced human salespeople to support startups accelerate revenue growth.

How much funding has Monaco raised?

Monaco has raised $35 million in funding, including a $10 million seed round and a $25 million Series A round.

Who are Monaco’s competitors?

Monaco’s competitors include Salesforce, HubSpot, Attio, Clay, and a growing number of AI-powered sales startups.

What makes Monaco different?

Monaco’s key differentiator is its “human-in-the-loop” approach, which combines AI automation with the expertise of experienced salespeople.

Who is Monaco targeting?

Monaco is primarily targeting seed and Series A-level startups.

Did you know? Monaco’s founders, Sam and Brian Blond, both have backgrounds in venture capital and sales, giving them a unique perspective on the challenges faced by early-stage companies.

Pro Tip: When evaluating AI sales tools, consider the level of human oversight and support offered. A hybrid approach can often deliver better results than fully automated solutions.

What are your thoughts on the future of AI in sales? Share your insights in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Tech

Ghostbusters: Spirits Unleashed Now $2.99 for Xbox Game Pass Subscribers

by Chief Editor
written by Chief Editor

Ghostbusters Bargains Signal Broader Trend: Discounted Games & Evolving Support Models

Xbox and PlayStation players are currently enjoying significant discounts on Ghostbusters: Spirits Unleashed – Ecto Edition, with the game available for just $2.99 for subscribers of Xbox Game Pass Essential or higher. This mirrors a recent PlayStation promotion, and highlights a growing trend of publishers offering substantial price reductions on titles, particularly those with ongoing or completed live service elements.

The Rise of the “Ecto Edition” and Complete Packages

The availability of the Ecto Edition, which includes all four DLC drops from 2023, is key to this deal. This practice of bundling post-launch content into a definitive edition is becoming increasingly common. It allows publishers to attract new players with a comprehensive experience, while also potentially incentivizing those who initially hesitated to purchase DLC separately. The DLC includes content inspired by Ghostbusters II, The Real Ghostbusters, and more.

Game Pass & PlayStation Deals: A Competitive Landscape

The parallel discounts on Xbox Game Pass and PlayStation demonstrate a competitive push to attract and retain gamers. Both platforms are leveraging popular titles like Ghostbusters: Spirits Unleashed to enhance the value proposition of their subscription services. This competition benefits consumers, providing access to a wider range of games at lower prices.

Beyond the Main Game: The Appeal of Cosmetic DLC

The discounted Ghostbusters Contract Access Pack, offering a wealth of cosmetic items, illustrates another trend: the continued monetization of games through optional, non-essential content. While the core gameplay experience remains accessible, players can personalize their experience with unique outfits and gear inspired by various Ghostbusters iterations. This allows players to support the game even after major development has ceased.

Shifting Development Focus & Long-Term Game Support

Developer IllFonic has officially ended active development on new DLC for Ghostbusters: Spirits Unleashed, shifting its focus to a new project based on John Carpenter’s work. Here’s a common scenario in the games industry, where developers move on to new ventures after a period of post-launch support. However, the continued availability of the game and its servers ensures that players can still enjoy the complete experience.

The Future of Asymmetrical Multiplayer

Ghostbusters: Spirits Unleashed utilizes an asymmetrical 4v1 multiplayer format. While development has ceased, the game’s success demonstrates the enduring appeal of this genre. Expect to see more developers experimenting with asymmetrical gameplay in the future, offering unique and engaging experiences that deviate from traditional multiplayer modes.

FAQ

  • Is Ghostbusters: Spirits Unleashed still playable online? Yes, the servers remain active, and players can continue to enjoy the game online.
  • What does the Ecto Edition include? It includes the base game and all four DLC drops released in 2023.
  • Is the discount available to all Xbox players? No, the $2.99 price is exclusive to Xbox Game Pass Essential subscribers and higher tiers.
  • Will there be any new content added to the game? No, IllFonic has confirmed that active development has ended.

Pro Tip: Check both the Xbox and PlayStation stores regularly for flash sales and limited-time offers on your favorite games. Subscribing to gaming newsletters can also keep you informed about upcoming discounts.

Don’t miss out on these incredible deals! Explore the Ghostbusters: Spirits Unleashed universe and join the hunt (or haunt) today. Buy now on Xbox or get it on PlayStation.

0 comments
0 FacebookTwitterPinterestEmail
Tech

First Look at Eidos-Montréal’s Cancelled LOTR Game

by Chief Editor
written by Chief Editor

Eidos-Montréal’s Lost Visions: From Legacy of Kain to Lord of the Rings and Beyond

Eidos-Montréal, the studio behind acclaimed titles like the recent Tomb Raider games, is currently navigating a challenging period. Following its acquisition by Embracer Group, the studio has experienced layoffs and a wave of project cancellations, signaling a shift from independent development towards support work for other studios.

The Scrapped Legacy of Kain Reboot

Among the casualties was a “soft-reboot” of the beloved Legacy of Kain franchise. Development, codenamed P16, lasted approximately one year before Embracer pulled the plug, transferring the IP back to Crystal Dynamics. Sources indicate the project was progressing well, with “barebones gameplay” already established, showcasing a promising vision for a modern take on the gothic vampire world.

A Glimpse into a Cancelled Lord of the Rings Game

Beyond Legacy of Kain, Eidos-Montréal was also working on a Lord of the Rings game. This project, described as a “Dark Fantasy ARPG,” featured a top-down perspective and incorporated card-based mechanics with a narrative style reminiscent of Telltale Games. Concept art reveals detailed environments, including the port city of Umbar and the iconic Prancing Pony inn.

Umbar and the Corsair Threat

The concept art focuses heavily on Umbar, a pirate stronghold in Tolkien’s world. Images depict the city before and after a potential battle, showcasing its destruction. Early gameplay tests included red silhouettes identified as “Corsairs,” suggesting a focus on the pirates of Umbar as antagonists.

The Fate of the Tolkien Project

Like the Legacy of Kain reboot, the Lord of the Rings game was cancelled following the Embracer acquisition. The extent of development remains unclear, but the available concept art offers a tantalizing glimpse into what could have been.

Shifting Focus: From Original IPs to Support Roles

The cancellations have forced Eidos-Montréal into a support role, assisting other studios on projects like Fable and Grounded 2. The studio was even approached to contribute to Hideo Kojima’s Overdose, but reportedly declined due to staffing requirements.

P11: A New Hope?

Despite the setbacks, Eidos-Montréal is currently developing a new internal project, codenamed P11. This is described as a third-person, open-world action-adventure IP built on Unreal Engine 5.

The Broader Implications for Game Development

The situation at Eidos-Montréal highlights a growing trend within the gaming industry: the increasing consolidation of studios and the impact of acquisitions on creative projects. The cancellation of promising titles like the Legacy of Kain reboot and the Lord of the Rings game underscores the risks associated with relying on large corporations to fund and support ambitious game development.

Did you know?

Eidos-Montréal has cancelled as many as 7-8 projects in recent years, indicating a significant shift in the studio’s direction.

FAQ

Q: What happened to the Legacy of Kain reboot?
A: It was cancelled by Embracer Group after approximately one year of development and the IP was returned to Crystal Dynamics.

Q: What kind of game was the Lord of the Rings project?
A: It was a “Dark Fantasy ARPG” with a top-down perspective and card-based mechanics.

Q: What is Eidos-Montréal working on now?
A: The studio is currently developing a new internal project, codenamed P11, a third-person, open-world action-adventure game.

Q: Why were these projects cancelled?
A: The cancellations occurred following Embracer Group’s acquisition of Eidos-Montréal, as the company restructured its priorities.

Explore more about the gaming industry’s evolving landscape and the challenges faced by developers on our news page. Share your thoughts on these cancelled projects in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

How AI is helping solve the labor issue in treating rare diseases

by Chief Editor
written by Chief Editor

AI: The Novel Hope for Rare Disease Treatment

Modern biotechnology has made incredible strides in gene editing and drug design, yet a staggering number of rare diseases remain without effective treatments. The bottleneck isn’t a lack of scientific tools, but a critical shortage of skilled professionals to drive the research forward. Increasingly, artificial intelligence is emerging as the key to unlocking progress, acting as a “force multiplier” for scientists tackling previously intractable challenges.

Pharmaceutical Superintelligence: A New Era of Drug Discovery

Insilico Medicine is at the forefront of this revolution, aiming to develop what its president, Alex Aliper, calls “pharmaceutical superintelligence.” The company recently launched its “MMAI Gym,” a platform designed to train generalist large language models – like ChatGPT and Gemini – to match the performance of specialized AI models in drug discovery. This approach promises to dramatically increase productivity in an industry facing a talent crunch.

Insilico’s platform works by ingesting vast amounts of biological, chemical, and clinical data to generate hypotheses about disease targets and potential therapeutic molecules. By automating tasks traditionally performed by teams of chemists and biologists, the company can accelerate the drug discovery process and reduce costs. A recent example of this involved using AI to identify existing drugs that could be repurposed to treat ALS, a rare neurological disorder, leading to a Phase II clinical study.

Beyond Discovery: Solving the Delivery Problem with AI

The challenge extends beyond simply identifying potential therapies. Many diseases require precise interventions at a fundamental biological level, necessitating advancements in gene editing delivery. GenEditBio is tackling this “delivery bottleneck” with its NanoGalaxy platform, which leverages AI to analyze how chemical structures interact with specific tissues.

GenEditBio’s approach focuses on in vivo gene editing – delivering the editing tools directly into the body – aiming for a one-time injection that permanently corrects the genetic defect. The AI predicts how to modify the delivery vehicle’s chemistry to avoid triggering an immune response, streamlining a historically complex and difficult-to-scale process. The company recently received FDA approval to commence trials of CRISPR therapy for corneal dystrophy, a significant milestone.

The Data Challenge: A Persistent Hurdle

Despite the promise of AI, progress in biotech is still hampered by a fundamental data problem. AI models require massive datasets of high-quality information to accurately model the complexities of human biology. Currently, much of the available data is biased towards populations in the Western world.

“We still need more ground truth data coming from patients,” Aliper emphasized. “The corpus of data is heavily biased… I think we need to have more efforts locally, to have a more balanced set of original data.” Insilico addresses this by generating multi-layer biological data from disease samples using automated labs, feeding this information back into its AI platform.

Still, there’s too a wealth of information already encoded within the human genome itself. Much of our DNA doesn’t directly code for proteins but acts as an instruction manual for gene behavior. AI models, like Google DeepMind’s AlphaGenome, are increasingly capable of deciphering this complex information.

The Future: Digital Twins and Personalized Medicine

Looking ahead, Aliper envisions a future where digital twins of humans are used to conduct virtual clinical trials. While still in its early stages, this technology could significantly accelerate the development of new therapies and reduce the costs associated with traditional clinical trials.

The FDA currently approves around 50 new drugs annually, a number that needs to increase to address the growing burden of chronic diseases. Aliper hopes that, within the next 10 to 20 years, more personalized treatment options will become available, offering hope to patients with rare and neglected disorders.

Frequently Asked Questions

  • What is “pharmaceutical superintelligence”? It refers to the development of AI systems capable of solving multiple drug discovery tasks with superhuman accuracy.
  • What is in vivo gene editing? This involves delivering gene editing tools directly into the body to correct genetic defects.
  • Why is data quality important for AI in biotech? AI models require large, high-quality datasets to accurately model the complexities of human biology.
  • What is the MMAI Gym? It’s Insilico Medicine’s platform for training generalist large language models for drug discovery.

Pro Tip: Keep an eye on companies like Insilico Medicine and GenEditBio. They are pioneering the use of AI to overcome long-standing challenges in rare disease treatment.

Did you know? The FDA approved 50 new drugs in 2025, highlighting the ongoing need for innovation in pharmaceutical development.

What are your thoughts on the role of AI in healthcare? Share your comments below and join the conversation!

0 comments
0 FacebookTwitterPinterestEmail
Business

Amazon and Google are winning the AI capex race — but what’s the prize?

by Chief Editor
written by Chief Editor

The AI Arms Race: Why Tech Giants Are Spending Billions on Data Centers (and Why Wall Street is Nervous)

The tech world is currently locked in a high-stakes spending spree, fueled by the belief that computational power will be the defining advantage in the age of artificial intelligence. It’s a race to build the biggest, most powerful data centers, with Amazon, Google, and Meta leading the charge. But this isn’t the traditional path to success – building a profitable business usually involves reducing costs, not dramatically increasing them. So, what’s driving this seemingly counterintuitive behavior?

Amazon Takes the Lead in Infrastructure Investment

Amazon’s recent earnings report revealed a projected $200 billion in capital expenditures for 2026, a significant jump from the $131.8 billion spent in 2025. While a substantial portion is earmarked for AI, Amazon’s diverse operations – including robotics and satellite technology – complicate a simple AI-centric analysis. This contrasts with competitors who are more heavily focused on AI alone.

Google isn’t far behind, forecasting between $175 billion and $185 billion in capex for 2026, more than doubling its previous year’s spending. Meta is committing $115 billion to $135 billion, while Oracle plans $50 billion. Microsoft, though lacking a formal 2026 projection, is currently on track for around $150 billion annually. These figures represent a massive bet on the future of compute.

The Logic Behind the Spending: Compute as the New Oil

The core idea is that AI’s potential is limited only by available computing power. Companies that control their own infrastructure will be best positioned to innovate and dominate the AI landscape. This is particularly true for generative AI models, which require enormous amounts of processing power for both training and inference. Nvidia, the leading provider of AI chips, is benefiting immensely from this trend, with its stock soaring as demand for its GPUs outstrips supply.

Did you know? The energy consumption of training a single large language model can be equivalent to the lifetime emissions of five cars.

Wall Street’s Reaction: A Vote of No Confidence?

Despite the compelling logic, investors are reacting negatively to these massive spending plans. Stock prices for these tech giants have fallen as these capital expenditure projections were announced. The market appears to be questioning whether the potential returns will justify the enormous upfront investment. This skepticism isn’t limited to companies still defining their AI product strategies, like Meta; even established players like Microsoft and Amazon are facing investor scrutiny.

This disconnect highlights a fundamental tension: the long-term strategic importance of AI versus the short-term pressure to deliver profits. The market often prioritizes immediate financial results over future potential.

Beyond the Big Five: The Rise of Specialized AI Infrastructure Providers

While the tech giants are building out their own infrastructure, a growing ecosystem of specialized AI infrastructure providers is emerging. Companies like CoreWeave and Lambda Labs are offering cloud-based access to powerful GPUs, catering to startups and researchers who can’t afford to build their own data centers. This trend could democratize access to AI compute, potentially challenging the dominance of the big tech companies.

Pro Tip: Consider exploring specialized AI cloud providers if you’re a startup or researcher needing access to high-end compute without the capital expenditure.

The Future of AI Infrastructure: Efficiency and Innovation

The current spending spree is unlikely to continue indefinitely. As AI models become more efficient and new hardware architectures emerge, the demand for raw compute power may moderate. Innovation in areas like chip design (e.g., RISC-V) and data compression could significantly reduce the cost of AI training and inference. Furthermore, advancements in software optimization and algorithmic efficiency will play a crucial role in maximizing the utilization of existing infrastructure.

The focus will likely shift from simply building more data centers to optimizing existing resources and developing more sustainable AI solutions. This includes exploring alternative cooling technologies, utilizing renewable energy sources, and reducing the carbon footprint of AI operations.

FAQ: AI Infrastructure Spending

  • Why are tech companies spending so much on data centers? They believe controlling compute power is crucial for success in the AI era.
  • Is this spending sustainable? Probably not at the current rate. Efficiency gains and new technologies will likely reduce the need for massive infrastructure expansion.
  • What does this mean for investors? Investors are currently skeptical, leading to stock price declines.
  • Will smaller companies be able to compete? Specialized AI infrastructure providers are emerging, offering access to compute for those without the resources to build their own.

Reader Question: “Will the focus on AI infrastructure lead to a shortage of electricity?” – This is a valid concern. The increasing demand for power from data centers is putting a strain on energy grids in some regions. Addressing this will require significant investments in renewable energy and grid modernization.

Explore our other articles on the future of AI and cloud computing to stay informed about the latest trends.

Subscribe to our newsletter for weekly updates on AI, technology, and the future of business.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts